The dual-action formula helps convert fatty acids into energy while maintaining muscle tone, making it ideal for fitness enthusiasts and individuals looking for a non-surgical fat loss solution
What it is not: a replacement for a GLP-1 medication, and not a treatment for stress, appetite, or any medical condition
Your racial or ethnic origin, religious or philosophical beliefs, or union membership
Phase 2 data (published 2023) Phase 2 results published in the New England Journal of Medicine in 2023 provided the first substantial evidence for the mechanism, reporting dose-dependent body-weight reductions reaching approximately 24% at the highest doses, HbA1c improvements comparable to or exceeding tirzepatide, a safety profile dominated by gastrointestinal tolerability effects, and energy-expenditure increases documented by indirect calorimetry
Hormone-sensitive lipase expression and IHC localization in the rat ovary, oviduct, and uterus
Net income grew 139.2% to $373.7 million
